Description:
The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
Clinical Trials /
MR-Guided Cryoablation of Prostate Bed Recurrences
NCT01727284
Related Conditions:
- Prostate Neoplasm
Recruiting Status:
Active, not recruiting
Phase:
N/A
Trial Eligibility
Document
Title
- Brief Title: MR-Guided Cryoablation of Prostate Bed Recurrences
- Official Title: Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences
Clinical Trial IDs
- ORG STUDY ID: 12-002245
- NCT ID: NCT01727284
Conditions
- Prostate Tumors
Purpose
The purpose of this research is to see if MR-guided cryoablation can effectively treat
prostate tumor recurrences.
Trial Arms
| Name | Type | Description | Interventions |
|---|---|---|---|
| MR-guided cryoablation (freezing of tissue and/or tumors) | Other |
Eligibility Criteria
Inclusion Criteria:
- Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa
- Surgery is not a desirable alternative therapy at the time of enrollment
- Radiation therapy has failed or not indicated or can be safely postponed
- Tumor size is < 5 cm at its largest diameter
- Tumor does not encompass the rectal wall or external urethral sphincter
- Performance status is ECOG 2 or better in adults
- Patient is able to undergo MRI
Exclusion Criteria:
- Patients with pacemaker or defibrillator
| Maximum Eligible Age: | 100 Years |
| Minimum Eligible Age: | 30 Years |
| Eligible Gender: | Male |
| Healthy Volunteers: | No |
Primary Outcome Measures
| Measure: | Evaluation of target lesion at 3-6, 12, 24, and 36 month imaging follow-up |
| Time Frame: | 3 years |
| Safety Issue: | |
| Description: |
Details
| Phase: | N/A |
| Primary Purpose: | Interventional |
| Overall Status: | Active, not recruiting |
| Lead Sponsor: | Mayo Clinic |
Last Updated
February 4, 2021
